Back to search

Article

An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participants

2022-06-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The QRISK3 cardiovascular disease (CVD) risk prediction model was derived using primary care data; however, it is frequently used outside of clinical settings. The use of QRISK3 in epidemiological studies without external validation may lead to inaccurate results, however it has been used multiple times on data from UK Biobank. We aimed to externally evaluate the performance o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0211fe4e-eb78-597d-b460-6499e986e5d4
DOI
10.1101/2022.06.30.22277083
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participantsDOI 10.1101/2022.06.30.22277083
Cardiovascular risk scores for primary prevention: head-to-head validation of 16 established and contemporary modelsSemantic proximity
Comparative Validation of ASCVD, Framingham Risk Score, Globorisk, and PREVENT for 10-Year Cardiovascular Risk Prediction in the UK BiobankSemantic proximity
Development and validation of a next-gen health stratification engine to determine risk for multiple cardiovascular diseasesSemantic proximity
Actionable absolute risk prediction of atherosclerotic cardiovascular disease: a behavior-management approach based on data from 464,547 UK Biobank participantsSemantic proximity
Performance and Calibration of ASCVD, Framingham, and Globorisk Models in a Large UK Biobank Cohort: A 10-Year Longitudinal Outcome AnalysisSemantic proximity
Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithmSemantic proximity
Development and validation of decision rules models to stratify coronary artery disease, diabetes, and hypertension risk in preventive care: cohort study of returning UK Biobank participantsSemantic proximity
Development and validation of a risk prediction algorithm for high-risk populations combining genetic and conventional risk factors of cardiovascular diseaseSemantic proximity
Improving cardiovascular risk prediction beyond pooled cohort equations: a prospective cohort of 304,356 participantsSemantic proximity
Prediction of Coronary Artery Disease and Major Adverse Cardiovascular Events Using Clinical and Genetic Risk Scores for Cardiovascular Risk Factors.Semantic proximity
Generalisability of Results from UK Biobank: Comparison With a Pooling of 18 Cohort StudiesSemantic proximity
A plasma proteomic signature for atherosclerotic cardiovascular disease risk prediction in the UK Biobank cohortSemantic proximity
Select a neighboring publication to make it the new centre.